Morgan Stanley »

Neurocrine Biosciences shares owned by Morgan Stanley

Quarter-by-quarter ownership of Neurocrine Biosciences (NBIX) shares owned by Morgan Stanley from 13F filings

Historical chart of Morgan Stanley investment in Neurocrine Biosciences

Tip: Access up to 7 years of quarterly data

All positions including Neurocrine Biosciences held by Morgan Stanley consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Neurocrine Biosciences by Morgan Stanley

Quarter filed Position value Share count Share price at filing
2023-09-30 $217M 1.9M 112.50
2023-06-30 $176M 1.9M 94.30
2022-12-31 $245M 2.0M 119.44
2022-06-30 $46M 487k 95.24
2022-03-31 $17M 177k 93.50
2021-06-30 $35M 350k 99.06
2020-12-31 $12M 125k 95.85
2020-09-30 $27M 283k 96.83
2020-06-30 $18M 146k 121.90
2020-03-31 $7.0M 81k 86.55
2019-12-31 $17M 160k 107.48
2019-09-30 $7.4M 83k 89.74
2019-03-31 $7.8M 89k 88.11
2018-12-31 $11M 156k 71.43
2018-09-30 $26M 214k 123.02
2018-06-30 $9.5M 97k 98.27
2018-03-31 $15M 185k 83.01
2017-12-31 $4.0M 51k 77.60
2017-03-31 $1.3M 31k 43.34
2016-12-31 $1.8M 47k 38.65
2016-09-30 $2.2M 41k 52.94
2016-06-30 $2.9M 64k 45.44
2016-03-31 $0 38k 0.00
2015-12-31 $0 66k 0.00
2015-09-30 $1.9M 47k 39.78
2015-06-30 $1.5M 31k 47.79
2014-12-31 $2.2M 99k 22.33
2014-09-30 $787k 50k 15.68
2014-06-30 $517k 35k 14.85
2014-03-31 $340k 21k 16.10
2013-12-31 $467k 50k 9.34
2013-09-30 $520k 46k 11.29